Tools for Biocompatibility Evaluation with Different Dialysis Membranes
Yuh‐Feng Lin,Shichun Yang,Liang-Kuang Diang,Wen-Chen Tsai,Shih‐Hua Lin,Pui S Chu,Yang Liu,Shang-Der Shieh
2000-01-01
Abstract:Among the several major contributors to the mortality and morbidity of chronic hemodialysis patients, systemic reactions arising from acute and chronic exposure to extracorporeal materials in an important one. In this study we applied C3s, leukocyte count, PaO2, cytokines (IL-2R, TNFα, IL-6) and s2 microglobulin to evaluate biocompatibility among different hollow fibers [ Cuprophane (Cu), cellulose acetate (CA), hemophane (HP), PMMA, polysulfone ETO (PS-E), polysulfone steam (PS-S) and PS2000] sequentially in 8 chronic hemodialysis patients. Our results have demonstrated increased C3a at 30′ vs baseline of hemodialysis with Cu (2555.8 ± 431.0 vs 507.8 ± 48.1 ng/ml.p＜0.001). CA(1773.29±240.74 vs 787.37 ± 230.25 ng/ml.p＜0.01), PH(2466.68±154.24 vs 253.54±56.87 ng/ml,p＜0.001) There was no significant elevation of C3a at 30′ (vs baseline)when membranes of PMMA, PS-E, PS-S or PS 2000 were applied. There were significant decrement of PaO2 and WBC at 30′ of HD (vs baseline) with nonsynthetic membranes as compared to synthetic membranes. There was good correlation between increment of serum C3a and decrement of leukocyte at 30′ of HD. There were more IL-2R and IL-6 production with nonsynthetic membranes as compared to synthetic membrane. Synthetic membranes showed more s2 microglobulin removal during one section of dialysis (PS-E 36824.8 ± 3513.3 vs 13441.2 ± 1376.1 μg/ml, p ＜ 0.01; PS-S37174.2 ± 3566.2 vs 14618.0 ± 1706.1 μg/ml. p ＜ 0.01; PS 2000 39512.7 ± 3607.0 vs 21277.0 ± 1422.3 μg/ml, p ＜ 0.05) while nonsynthetic membranes did not remove s2 microglobulin. Removal of s2 microglobulin are mainly through adsoption route as evaluated from measurement of dialysate s2 microglobulin/ In conclusion synthetic membranes did not trigger complement activation, leukocyte sequestration, hypoxemia, cytokine production while remove more s2 microglobulin as compared to those of onsynthetic membranes. Clinically, we can evaluate biocompatibility simply form leukocyte determination and measurement of s2 microglobulin. Synthetic biocompatible membranes might result in better long term dialysis outcome.